In their final week before the holidays, lawmakers in Congress will consider several health-care proposals. Subsidies for ...

Even so, in an interview with The Economist, Mr Doustdar sounded confident that Novo can recover. His prescription is to push a new generation of obesity treatments while making sweeping changes to ...

New Zealand compares well on global measures of freedom, happiness and transparency. But rankings in some important areas, ...

Sharp differences in employment patterns have developed across Sydney, with half of workers in some suburbs doing part-time ...

The SAR government on Friday announced that it had appointed a former Law Society president as the director of the ...

For Mariame Condé, the seed-collecting work came at a critical time. In January 2022, she was pregnant and nearly out of food ...

The Blood Moon Pack has had a rough couple of years. The male, named Y1T and known for distinct dark streaks on his face, had produced a litter of pups with his mate in the spring of 2024, but none ...

Nigeria’s banking sector has continued to impress in 2025, with some banks posting solid profits despite the economic ...

The jobs report for November provided fresh evidence of softening in the labor market, but it isn’t likely to change the ...

The U.S. economy was buffeted by waves of stormy factors in 2025 including erratic trade policy changes, pesky inflationary ...

Novo, however, vastly underestimated the appetite for its new weight-loss jab. Mr Doustdar says it planned for demand to be three times that of Saxenda, an older and less-effective weight-loss drug.

The use of adjustable-rate mortgages is rising as borrowing costs remain high, but housing experts don't see the same risks ...